Veradigm Total Liabilities 2012-2022 | MDRX
Veradigm total liabilities from 2012 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
|
Veradigm Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $548 |
| 2023 | $498 |
| 2022 | $487 |
| 2021 | $951 |
| 2020 | $1,251 |
| 2019 | $1,921 |
| 2018 | $1,601 |
| 2017 | $3,070 |
| 2016 | $2,559 |
| 2015 | $1,263 |
| 2014 | $1,180 |
| 2013 | $1,302 |
| 2012 | $1,065 |
| 2011 | $1,027 |
|
Veradigm Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2022-12-31 | $487 |
| 2022-09-30 | $514 |
| 2022-06-30 | $518 |
| 2022-03-31 | $1,077 |
| 2021-12-31 | $951 |
| 2021-09-30 | $1,066 |
| 2021-06-30 | $1,147 |
| 2021-03-31 | $1,193 |
| 2020-12-31 | $1,251 |
| 2020-09-30 | $1,938 |
| 2020-06-30 | $1,946 |
| 2020-03-31 | $2,011 |
| 2019-12-31 | $1,921 |
| 2019-09-30 | $1,949 |
| 2019-06-30 | $1,919 |
| 2019-03-31 | $1,786 |
| 2018-12-31 | $1,601 |
| 2018-09-30 | $3,401 |
| 2018-06-30 | $3,212 |
| 2018-03-31 | $3,260 |
| 2017-12-31 | $3,070 |
| 2017-09-30 | $2,737 |
| 2017-06-30 | $2,619 |
| 2017-03-31 | $2,610 |
| 2016-12-31 | $2,559 |
| 2016-09-30 | $2,440 |
| 2016-06-30 | $2,359 |
| 2016-03-31 | $1,235 |
| 2015-12-31 | $1,263 |
| 2015-09-30 | $1,278 |
| 2015-06-30 | $1,312 |
| 2015-03-31 | $1,227 |
| 2014-12-31 | $1,180 |
| 2014-09-30 | $1,288 |
| 2014-06-30 | $1,293 |
| 2014-03-31 | $1,327 |
| 2013-12-31 | $1,302 |
| 2013-09-30 | $1,307 |
| 2013-06-30 | $1,308 |
| 2013-03-31 | $1,289 |
| 2012-12-31 | $1,065 |
| 2012-09-30 | $1,109 |
| 2012-06-30 | $1,200 |
| 2012-03-31 | $1,062 |
| 2011-12-31 | $1,027 |
| 2011-09-30 | $988 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.597B | $0.594B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.890B | 42.79 |
| Tempus AI (TEM) | United States | $12.625B | 0.00 |
| 10x Genomics (TXG) | United States | $9.470B | 0.00 |
| Hinge Health (HNGE) | United States | $7.563B | 72.66 |
| Hims & Hers Health (HIMS) | United States | $6.533B | 0.00 |
| Doximity (DOCS) | United States | $4.624B | 28.50 |
| Heartflow (HTFL) | United States | $4.200B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.686B | 243.09 |
| Privia Health (PRVA) | United States | $2.602B | 97.00 |
| Clover Health Investments (CLOV) | United States | $2.422B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.05 |
| Butterfly Network (BFLY) | United States | $1.933B | 0.00 |
| Schrodinger (SDGR) | United States | $1.767B | 0.00 |
| Omnicell (OMCL) | United States | $1.475B | 21.06 |
| Azenta (AZTA) | United States | $1.455B | 79.07 |
| Enovis (ENOV) | United States | $1.076B | 5.57 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.669B | 0.00 |
| Phreesia (PHR) | United States | $0.636B | 34.13 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Claritev (CTEV) | United States | $0.569B | 0.00 |
| Evolent Health (EVH) | United States | $0.423B | 0.00 |
| Carlsmed (CARL) | United States | $0.418B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.379B | 0.00 |
| CapsoVision (CV) | United States | $0.300B | 0.00 |
| Standard BioTools (LAB) | United States | $0.278B | 0.00 |
| American Well (AMWL) | United States | $0.221B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.147B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.089B | 6.53 |
| Pulmonx (LUNG) | United States | $0.084B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.063B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.060B | 0.00 |
| Outset Medical (OM) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.050B | 0.00 |
| Precipio (PRPO) | United States | $0.048B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.034B | 0.00 |
| 111 (YI) | China | $0.030B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.025B | 0.00 |
| HeartBeam (BEAT) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.019B | 0.00 |
| HeartSciences (HSCS) | United States | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |